Ultragenyx pharmaceutical inc. (RARE)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Revenues:
Total revenues

121,851

103,714

84,382

70,345

58,990

51,495

35,432

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Cost of sales

5,053

9,008

4,408

1,998

1,373

1,146

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

392,211

357,355

345,912

315,809

296,599

293,998

283,907

274,278

255,879

231,644

220,863

209,162

194,058

183,204

177,023

158,016

137,788

114,737

83,693

66,843

54,978

45,967

40,650

34,558

30,518

27,829

0

0

0

Selling, general and administrative

170,211

161,524

154,123

144,212

135,118

127,724

130,968

123,372

112,659

99,909

81,997

75,681

70,414

64,936

56,721

49,770

42,070

33,001

24,830

17,579

12,963

10,811

8,710

6,728

5,354

4,451

0

0

0

Total operating expenses

567,475

527,887

504,443

462,019

433,090

422,868

415,515

398,017

368,764

331,554

302,860

284,843

264,472

248,140

233,744

207,786

179,858

147,738

108,523

84,422

67,941

56,778

49,360

41,286

35,872

32,280

0

0

0

Loss from operations

-445,624

-424,173

-420,061

-391,674

-374,100

-371,373

-377,867

-371,934

-355,475

-328,942

-302,657

-284,727

-264,339

-248,007

-233,616

-207,769

-179,858

-147,738

-108,523

-84,422

-67,941

-56,778

-49,360

-41,286

-35,872

-32,280

0

0

0

Interest income

13,071

13,238

13,095

12,506

10,891

9,542

7,639

6,026

4,729

4,074

4,262

4,067

3,887

3,789

3,795

3,546

3,031

2,320

1,597

1,095

788

608

472

369

283

216

0

0

0

Gain from sale of priority review vouchers

-

-

-

-

-

170,300

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of investment in Arcturus equity securities

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense on liability related to the sale of future royalties

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net:
Other expense

-831

-787

-928

-922

-1,042

-5,588

-7,439

-3,919

990

6,530

6,753

3,334

-920

-1,621

14

91

-169

-200

-210

-426

-398

-3,632

-5,582

-6,132

-6,402

-3,006

0

0

0

Total other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,809

3,637

2,862

2,120

1,387

669

390

-3,024

-5,772

-6,425

-6,095

-2,790

0

0

0

Loss before income taxes

-421,520

-399,444

-395,900

-370,262

-323,929

-197,097

-207,345

-199,505

-219,756

-318,338

-285,297

-262,997

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for income taxes

3,476

3,283

848

802

691

514

392

159

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-424,996

-402,727

-396,748

-371,064

-324,620

-197,611

-191,516

-183,433

-203,596

-302,139

-291,695

-277,375

-261,407

-245,874

-229,807

-204,132

-176,996

-145,618

-107,136

-83,753

-67,551

-59,802

-54,381

-46,960

-41,965

-35,070

0

0

0

Net income (loss) per share:
Basic

-

-

-

-

-

-

-

-

0.63

-

-

-

-1.63

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted

-

-

-

-

-

-

-

-

0.62

-

-

-

-1.63

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares used in computing net income (loss) per share:
Basic

-

-

-

-

-

-

-

-

48,190

-

-

-

41,841

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted

-

-

-

-

-

-

-

-

49,077

-

-

-

41,841

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-64,610

-66,537

-63,278

-60,522

-50,289

0

0

0

Net loss per share, basic and diluted

-2.05

-1.62

-1.96

-1.72

-1.82

-

-1.74

-1.06

-

-

-1.87

-1.72

-

-1.76

-1.64

-1.46

-1.35

-1.47

-1.03

-0.83

-0.63

-0.45

-0.50

-0.45

-0.85

-5.23

-3.48

-3.32

-2.84

Shares used in computing net loss per share, basic and diluted

57,995

57,871

57,707

57,519

53,209

-

50,319

49,819

-

-

42,471

42,346

-

40,796

39,551

39,028

38,970

38,915

38,268

35,937

34,008

31,753

31,631

30,055

21,582

3,756

3,621

3,257

2,893

Collaboration and License
Total revenues

96,470

83,493

67,867

55,297

46,569

41,693

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product Sales
Total revenues

22,766

20,221

16,515

15,048

12,421

9,802

0

0

0

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash Collaboration Royalty Revenue
Total revenues

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-